RAPAFLO - 52544-151-19 - (silodosin)

Alphabetical Index


Drug Information of RAPAFLO

Product NDC: 52544-151
Proprietary Name: RAPAFLO
Non Proprietary Name: silodosin
Active Ingredient(s): 4    mg/1 & nbsp;   silodosin
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of RAPAFLO

Product NDC: 52544-151
Labeler Name: Watson Pharma, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022206
Marketing Category: NDA
Start Marketing Date: 20090323

Package Information of RAPAFLO

Package NDC: 52544-151-19
Package Description: 90 CAPSULE in 1 BOTTLE, UNIT-DOSE (52544-151-19)

NDC Information of RAPAFLO

NDC Code 52544-151-19
Proprietary Name RAPAFLO
Package Description 90 CAPSULE in 1 BOTTLE, UNIT-DOSE (52544-151-19)
Product NDC 52544-151
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name silodosin
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20090323
Marketing Category Name NDA
Labeler Name Watson Pharma, Inc.
Substance Name SILODOSIN
Strength Number 4
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of RAPAFLO


General Information